Scarica l'app Stockscreener
75.02
0.19%
-0.14
Pre-mercato:
74.91
-0.11
-0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$75.16
Aprire:
$75.02
Volume 24 ore:
2.36M
Relative Volume:
0.70
Capitalizzazione di mercato:
$16.73B
Reddito:
$4.04B
Utile/perdita netta:
$557.10M
Rapporto P/E:
31.13
EPS:
2.4102
Flusso di cassa netto:
$916.70M
1 W Prestazione:
+0.19%
1M Prestazione:
-0.23%
6M Prestazione:
+18.59%
1 anno Prestazione:
+9.12%
Intervallo 1D:
$74.99
$75.13
Intervallo di 1 settimana:
$74.79
$75.17
Portata 52W:
$51.90
$75.34
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.02 | 16.77B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
541.34 | 193.82B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
208.35 | 59.10B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.67 | 39.35B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
260.70 | 37.88B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.71 | 34.17B | 27.43B | 1.27B | 1.01B | 1.5829 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-12 | Downgrade | Argus | Buy → Hold |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Aggiornamento | Argus | Hold → Buy |
| 2025-08-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-27 | Reiterato | Needham | Hold |
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening - Zacks Investment Research
61,780 Shares in Hologic, Inc. $HOLX Purchased by Campbell & CO Investment Adviser LLC - MarketBeat
Press Release: Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - 富途牛牛
As Blackstone and TPG pursue Hologic deal, Q1 results arrive Jan. 29 - Stock Titan
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - Barchart.com
Hologic’s $8.5 Billion LBO Loan Costs Tighten on Strong Demand - Bloomberg.com
What you need to know ahead of Hologic's earnings release - MSN
Hologic’s $8.5 billion LBO loan costs tighten on strong demandBloomberg News - TradingView — Track All Markets
Aug Macro: What are analysts price targets for Hologic IncEarnings Risk Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Nordea Investment Management AB Increases Stake in Hologic, Inc. $HOLX - MarketBeat
Skin Rejuvenation Devices Market Set for Rapid Expansion - openPR.com
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer ScreeningHologic, Inc. - Hologic, Inc. - Investor Relations
Body Contouring Market Top Key Players 20262035: Allergan - openPR.com
How Recent Analyst Moves Are Rewriting The Story For Hologic (NasdaqGS:HOLX) - Yahoo Finance
Argus Research Downgrades Hologic (HOLX) to Hold | HOLX Stock Ne - GuruFocus
Hologic (NASDAQ:HOLX) Downgraded by Argus to "Hold" - MarketBeat
Blackstone (BX) Involved in Hologic Acquisition Deal - GuruFocus
SG Americas Securities LLC Grows Position in Hologic, Inc. $HOLX - MarketBeat
Is Hologic Inc. stock affected by interest rate hikesPortfolio Update Summary & Daily Risk Controlled Trade Plans - Улправда
(HOLX) Risk Channels and Responsive Allocation - Stock Traders Daily
What market sentiment indicators show for Hologic Inc. (HO1) stock2025 Volatility Report & Growth Oriented Trading Recommendations - ulpravda.ru
Why Hologic Inc. stock is recommended by analystsJuly 2025 Big Picture & Fast Gain Stock Tips - ulpravda.ru
Hologic issues safety alert for breast biopsy needles - Radiology Business
Why Hologic Inc. stock appeals to analystsInflation Watch & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Will Hologic Inc. (HO1) stock test record highs in 20252025 Price Targets & Verified Swing Trading Watchlists - ulpravda.ru
Why Hologic Inc. stock is seen as undervaluedJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - ulpravda.ru
Will Hologic Inc. stock outperform Dow Jones indexGlobal Markets & High Accuracy Trade Signal Alerts - ulpravda.ru
Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Can Hologic Inc. stock deliver surprise earnings beatMarket Trend Review & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Will Hologic Inc. stock deliver consistent dividends2025 Macro Impact & Growth Focused Entry Point Reports - ulpravda.ru
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What You Need To Know Ahead of Hologic's Earnings Release - Barchart.com
Hologic Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc.HOLX - Prime Publishers, Inc.
Blackstone, TPG Deliver a $7 Billion Test to Risky Loan Market - Bloomberg.com
Assessing Hologic (HOLX) Valuation After Recent Three Month Share Price Momentum - Yahoo Finance
Is Hologic (HOLX) Pricing Look Interesting After Recent Flat Share Performance - Sahm
Is Hologic Inc. stock cheap compared to fundamentals2026 world cup usa national team round of 32 defensive leaders build up play tactical prediction statistical analysis - ulpravda.ru
Hologic downgraded to ’B+’ by S&P after take-private deal - Investing.com Nigeria
Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? - The Globe and Mail
How sustainable is Hologic Inc. stock dividend payout2026 world cup usa national team semifinals young talents build up play group prediction expert opinion - ulpravda.ru
Wall Street Banks Kick Off $7 Billion Loan Sale Tied to Hologic Buyout - Bloomberg.com
Hologic Mammography Market Size to Hit USD 8.82 Billion by 2035 - Precedence Research
Diagnostic Device Market to Reach USD 79.9 Billion by 2030 | - openPR.com
Hologic Trading Near 52-Week High: How Should You Play the Stock? - Finviz
Hologic Inc. stock underperforms Thursday when compared to competitors - MSN
Hologic says 2026 CVR is more challenging with stopped shipment of product - MSN
Key facts: Blackstone's stock down 10.2% in 2025; partners with TPG on Hologic - TradingView — Track All Markets
Agree To Buy Hologic At $70, Earn 1.4% Annualized Using Options - Nasdaq
The Future of Bone Sonometer Market 2032 Industry Forecast - openPR.com
Skin Rejuvenation Devices Market Forecast Report: Strategic - openPR.com
Hologic, Inc. $HOLX Shares Sold by Yousif Capital Management LLC - MarketBeat
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.76%
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):